Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition: Postmenopausal Osteoporosis Interventions: Drug: Pravastatin Sodium 80 MG; Drug: Placebo Sponsor: Peking University Third Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Orthopaedics | Osteoporosis | Pravastatin | Reclast | Research | Statin Therapy | Zometa